// App-Quantinova.ai

: Study TPX-100-5: Significant reduction in femoral bone shape change 12 months after IA TPX-100 correlates with tibiofemoral cartilage stabilization

Researchers

Presenter

  • D. McGuire

Principal Investigators

  • M. Bowes

  • A. Brett

  • M. Miller

  • Y. Kumugai

Medical Centers

  • OrthoTrophix, Oakland, CA

  • Imorphics, Manchester, United Kingdom

  • Imorphics, Oakland, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • TPX100

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved